Price $3.16 |
Market Cap
165.9M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
2.77
|
P/S
1.77
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-11.2K
|
FCF
-0.2
|
|
Op. Margin
-12.30%
|
Net Margin
-11.00%
|
ROE
-17.50%
|
ROI
-43.20%
|
|
ROA
-9.30%
|
EPS Growth
-759.20%
|
Current Ratio
2.1
|
Debt/Equity
7.90%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Regulus Therapeutics Inc (RGLS) | $1.23 | - | - | 113.1M | Strong Buy |
| Aravive Inc (ARAV) | $5.17 | - | - | 129.6M | Strong Buy |
| NuVasive, Inc. (NUVA) | $68.88 | - | - | 3.37B | Strong Buy |
| Escalon Medical Corp. (ESMC) | $0.40 | - | - | 2.6M | Strong Buy |
| Gilead Sciences, Inc. (GILD) | $66.38 | - | 4.30% | 81.21B | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
